Candriam SCA’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.7M | Sell |
|
|||||
|
2025
Q1 | $37.8M | Sell |
|
|||||
|
2024
Q4 | $38.6M | Sell |
|
|||||
|
2024
Q3 | $42.2M | Buy |
|
|||||
|
2024
Q2 | $26.6M | Buy |
|
|||||
|
2024
Q1 | $15M | Hold |
|
|||||
|
2023
Q4 | $12.5M | Sell |
|
|||||
|
2023
Q3 | $13.1M | Sell |
|
|||||
|
2023
Q2 | $13.2M | Sell |
|
|||||
|
2023
Q1 | $24.7M | Buy |
|
|||||
|
2022
Q4 | $23.2M | Sell |
|
|||||
|
2022
Q3 | $21.3M | Sell |
|
|||||
|
2022
Q2 | $20.5M | Buy |
|
|||||
|
2022
Q1 | $19.3M | Sell |
|
|||||
|
2021
Q4 | $32.1M | Sell |
|
|||||
|
2021
Q3 | $39.9M | Sell |
|
|||||
|
2021
Q2 | $37.2M | Buy |
|
|||||
|
2021
Q1 | $38.6M | Hold |
|
|||||
|
2020
Q4 | $40.1M | Sell |
|
|||||
|
2020
Q3 | $41.5M | Buy |
|
|||||
|
2020
Q2 | $28.1M | Buy |
|
|||||
|
2020
Q1 | $15.2M | Hold |
|
|||||
|
2019
Q4 | $15.6M | Buy |
|
|||||
|
2019
Q3 | $9.05M | Buy |
|